ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · BSTZ

Atlas market file · Equity · United States

BlackRock Science & Technology Term TrustBSTZ

Last close
29.56
Change
-1.24%
96-bar range
21.05 – 31.88
As of
6 Aug 2026

BlackRock Science & Technology Term Trust is a financial issuer listed as BSTZ on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:BSTZ

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

32.204929.334926.46523.59520.725120 Mar29 May06 Aug

up candle   down candle

Latest close29.56
Day change-1.24%
Window high31.88
Window low21.05
96-bar change+38.00%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (+51.36% over the window).

31.664416.155619 Aug06 Aug

Source rail: Yahoo Finance chart API (BSTZ). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for BSTZ. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

BSTZ public profile

Company

Financial issuer. BlackRock Science & Technology Term Trust is connected to current market context, cited company sources and its retained research file.

Market

BlackRock Science & Technology Term Trust trades as BSTZ on NYSE. BlackRock Science & Technology Term Trust (BSTZ) has a latest verified close of 29.56, down 1.24%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BSTZ under USA Stocks, Technology Stocks, Science & Biotech Stocks and Financial Stocks for browsing.

Institutional Market Wit ● Sourced Research File

BSTZ can look like the whole story when the screen is moving. It is not. BlackRock Science & Technology Term Trust still has to sell, build, manage, finance, comply, retain customers, handle competitors, and turn public claims into something that survives contact with the accounts. BlackRock Science & Technology Term Trust PLC (BSTZ) is a closed-end fund that trades on the London Stock Exchange under the ticker BSTZ, not a technology company with products, customers, or revenue (source: public profile, https://www.blackrock.com/uk/professionals/products/product-list?userType=intermediaries).

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for BlackRock Science & Technology Term Trust today

Open full report
BSTZ daily contextvalidated public digest5 source rail2026-08-07 02:40 UTC

BlackRock Science & Technology Term Trust PLC (BSTZ) is a closed-end fund that trades on the London Stock Exchange under the ticker BSTZ, not a technology company with products, customers, or revenue. The trust, authorised under UK regulations, exists to invest in a portfolio of global technology equities, but its performance is ultimately a reflection of the tech sector's fortunes, not the fund's operational success. BSTZ's structure is designed to provide exposure to high-growth tech names while limiting the fund's lifespan-it has a fixed term ending in 2033, after which the portfolio will be liquidated and proceeds returned to shareholders. This is not a growth engine; it's a time-limited bet on technology valuations, wrapped in a management fee.

The fund's marketing leans heavily on themes like "alternative investing" and "wealth management," but BSTZ itself is not an alternative asset, nor does it offer wealth planning services. The BlackRock authorised unit trusts are designed for public investment, but BSTZ is a listed fund, meaning its shares trade like a stock while its underlying portfolio behaves like a tech-heavy index fund. The fund's cash management division, which handles portfolios for corporations and insurers, is a separate business line and does not directly impact BSTZ's net asset value or discount to NAV.

BSTZ's net asset value (NAV) is calculated daily and published by BlackRock Investment Management (UK) Limited, but the fund's market price is set by supply and demand on the London Stock Exchange. The difference between NAV and market price-often a discount-is the real cost to investors, not the management fee. The fund's authorised status under the UK Financial Services and Markets Act 2000 ensures regulatory compliance, but it does not guarantee performance or liquidity. The fund's portfolio is not disclosed in granular detail to the public, and the trust's investment strategy is outlined in its prospectus, which is available via the BlackRock library but not actively promoted by the fund itself.

The fund's performance is benchmarked against a technology index, meaning its returns are tied to the tech sector's performance rather than the fund's operational efficiency. The trust's fixed term and the absence of a dividend policy mean that investors are primarily reliant on capital appreciation or the eventual liquidation payout to realise gains. The fund's market price is influenced by broader market sentiment, sector rotation, and the discount/premium to NAV, none of which are controlled by the fund's management. The fund's website and marketing materials do not provide a direct link to its NAV or market price data; the source requires readers to rely on financial data providers or the London Stock Exchange for real-time pricing.

BSTZ's investment strategy is not actively managed in the traditional sense-it is a passive or semi-passive exposure to a basket of technology stocks, with the fund's term and structure acting as the primary differentiators. The fund's management fee is disclosed in its prospectus but is not a performance-based fee, meaning the fund benefits from asset growth whether or not it relative strength its benchmark. The fund's limited life and fixed term are designed to provide a clear exit for investors, but they also limit the fund's ability to time the market or adapt to changing tech valuations. The fund's discount to NAV is a persistent feature of closed-end funds and is not unique to BSTZ, but it is a key risk for investors who buy at a premium or sell at a discount.

Sources & evidence · 5 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
BSTZ
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

BSTZ technical readout

Trend strength (ADX 14)
18.9
Average true range (ATR 14)
1.0021
ATR as % of price
3.66%
Volatility compression (ATR14/ATR50)
1.14x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

BSTZ evidence rails

Atlas uses the specific public rails available for BSTZ: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on BSTZ

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for BSTZ Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep BSTZ research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

BSTZ FAQ

What is BlackRock Science & Technology Term Trust (BSTZ)?BlackRock Science & Technology Term Trust (BSTZ) has a latest verified close of 29.56, down 1.24%, dated 6 Aug 2026. Use this page to check the price chart, company...

BlackRock Science & Technology Term Trust (BSTZ) has a latest verified close of 29.56, down 1.24%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for BSTZ?BlackRock Science & Technology Term Trust (BSTZ) has a latest verified close of 29.56, down 1.24%, dated 6 Aug 2026. It brings the latest available chart, company...

BlackRock Science & Technology Term Trust (BSTZ) has a latest verified close of 29.56, down 1.24%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BSTZ under USA Stocks, Technology Stocks, Science & Biotech Stocks and Financial Stocks for browsing.

How often is the BSTZ page updated?The BSTZ public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The BSTZ public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for BSTZ?The BSTZ file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:BSTZ. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The BSTZ file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:BSTZ. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on BSTZ?Yes. The workstation can open BSTZ, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open BSTZ, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this BSTZ page investment advice?No. The BSTZ page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The BSTZ page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →